New pain block combo aims to cut opioid use in heart surgery patients
NCT ID NCT07599748
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares three pain management approaches for 120 adults undergoing coronary artery bypass surgery: standard painkillers alone, standard plus a parasternal nerve block, or standard plus both parasternal and adductor canal blocks. The goal is to see if adding these nerve blocks reduces opioid use and improves recovery. Participants will be followed for 72 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- parasternal block and adductor canal block (nerve blocks with local anesthetic)
- What this could lead to
- If successful, this could lead to better pain control and less opioid use after heart bypass surgery, helping patients recover more comfortably.
- What could go wrong
- This is a small, early-stage trial that hasn't started recruiting yet. The nerve blocks may not provide significant extra pain relief, and there are always risks like infection or bleeding from the injections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zonguladk Bulent ecevit University
Zonguldak, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Software-Guided heart procedures: a new standard for coronary care?
- Can patients safely dispense their own pain medicine after surgery?
- Can a VR headset calm nerves before surgery?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program